NEW YORK (
) -- The ex-dividend date for
) is tomorrow, March 9, 2011. Owners of shares as of market close today will be eligible for a dividend of 33 cents per share. At a price of $84.95 as of 9:31 a.m. ET, the dividend yield is 0.5%.
The average volume for Shire has been 414,000 shares per day over the past 30 days. Shire has a market cap of $16 billion and is part of the
industry. Shares are up 17.2% year to date as of the close of trading on Monday.
Shire plc, together with subsidiaries, engages in the research, development, manufacture, sale, and distribution of pharmaceutical products. The company operates through two segments: Specialty Pharmaceuticals and Human Genetic Therapies. The company has a P/E ratio of 27, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 17.5.
TheStreet Ratings rates Shire as buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full